Sign in
Therapeutic compositions for age-related macular degeneration comprising a complement factor H with isoleucine at residue 62 and tyrosine at residue 402
Patent   Open access

Therapeutic compositions for age-related macular degeneration comprising a complement factor H with isoleucine at residue 62 and tyrosine at residue 402

Gregory S Hageman
United States Patent and Trademark Office
07/30/2013
pdf
Therapeutic compositions for age-related macular degeneration com1.30 MBDownloadView
PDM V1.0 Open Access

Abstract

The invention relates to Factor H gene polymorphisms and haplotypes associated with an elevated or a reduced risk of AMD. The invention provides methods and reagents for diagnosis and treatment of AMD.

Details

Metrics

12 File views/ downloads
13 Record Views